Efficient lentiviral transduction of herpesvirus saimiri immortalized T cells as a model for gene therapy in primary immunodeficiencies

Gene Therapy

Volumn 11, Issue 12, 2004, Pages 956-961

  Toscano, M G ^a   Frecha, C ^b   Ortega, C ^c   Santamaria M ^c   Martin F ^b,d   Molina, I J ^a  

^a UNIVERSITY OF GRANADA   (Spain)

^b HOSPITAL UNIVERSITARIO SAN CECILIO   (Spain)

^c UNIVERSITY OF CÓRDOBA   (Spain)

^d CSIC   (Spain)

Author keywords

Gene therapy model; Herpesvirus saimiri; Lentiviral vectors; Oncoretroviral vectors; Primary immunodeficiencies; T cells

Indexed keywords

ADENOVIRUS VECTOR; LENTIVIRUS VECTOR; VIRUS GLYCOPROTEIN;

ARTICLE; CELL FUNCTION; CELL IMMORTALIZATION; CELL LINE; CONTROLLED STUDY; DISEASE MODEL; DNA MODIFICATION; ENDOTHELIUM CELL; FEMALE; GENE EXPRESSION; GENETIC DISORDER; GENETIC TRANSDUCTION; HERPES VIRUS SAIMIRI; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNE DEFICIENCY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE; TRANSGENE; TUMOR CELL; VESICULAR STOMATITIS VIRUS; VIRAL GENE THERAPY; VIRUS INFECTION;

ADOPTIVE TRANSFER; ADULT; CELL LINE; FEMALE; GENE THERAPY; GENETIC VECTORS; HERPESVIRUS 2, SAIMIRIINE; HIV-1; HUMANS; LENTIVIRUS; LEUKEMIA VIRUS, MURINE; MALE; SEVERE COMBINED IMMUNODEFICIENCY; T-LYMPHOCYTES; TRANSDUCTION, GENETIC;

HERPESVIRIDAE; HUMAN IMMUNODEFICIENCY VIRUS 1; SAIMIRI; SAIMIRIINE HERPESVIRUS 2; VESICULAR STOMATITIS VIRUS;

EID: 3142688343     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3302259     Document Type: Article

References (36)

1. Molina IJ et al. T cell lines characterize events in the pathogenesis of the Wiskott-Aldrich syndrome. J Exp Med 1992; 176: 867-874.
2. Mitsuya H et al. Functional properties of antigen-specific T cells infected by human T-cell leukemia-lymphoma virus (HTLV-I). Science 1984; 225: 1484-1486.
3. Yssel H et al. Human T cell leukemia/lymphoma virus type I infection of a CD4+ proliferative/cytotoxic T cell clone progresses in at least two distinct phases based on changes in function and phenotype of the infected cells. J Immunol 1989; 142: 2279-2289.
4. Koga Y et al. Absence of transcription of lck (lymphocyte specific protein tyrosine kinase) message in IL-2-independent, HTLV-I-transformed T cell lines. J Immunol 1989; 142: 4493.
5. Biesinger B et al. Stable growth transformation of human T lymphocytes by Herpesvirus saimiri. Proc Natl Acad Sci USA 1992; 89: 3116-3119.
6. Weber F et al. Transformation of human T-cell clones by Herpesvirus saimiri: intact antigen recognition by autonomously growing myelin basic protein-specific T cells. Proc Natl Acad Sci USA 1993; 90: 11049-11053.
7. Fleckenstein B, Desrosiers RC. Herpesvirus saimiri and Herpesvirus ateles. In: Roizman B (ed) The Herpesviruses, Vol. 1. Plenum Press: New York, 1982, pp. 253-332.
8. Nava VE et al. Herpesvirus saimiri encodes a functional homolog of the human bcl-2 oncogene. J Virol 1997; 71: 4118-4122.
9. Thome M et al. Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors. Nature 1997; 386: 517-521.
10. Kraft MS et al. Herpesvirus saimiri transforms human T-cell clones to stable growth without inducing resistance to apoptosis. J Virol 1998; 72: 3138-3145.
11. Gallego MD et al. Defective actin reorganization and polymerization of Wiskott-Aldrich T-cells in response to CD3-mediated stimulation. Blood 1997; 90: 3089-3097.
12. Pacheco-Castro A et al. Signaling through a CD3 gamma-deficient TCR/CD3 complex in immortalized mature CD4+ and CD8+ T lymphocytes. J Immunol 1998; 161: 3152-3160.
13. Broker BM et al. Activation induces apoptosis in Herpesvirus saimiri-transformed T cells independent of CD95 (Fas, APO-1). Eur J Immunol 1997; 27: 2774-2780.
14. Naldini L et al. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 1996; 272: 263-267.
15. Kay MA, Glorioso JC, Naldini L. Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics. Nat Med 2001; 7: 33-40.
16. Haas DL et al. Critical factors influencing stable transduction of human CD34(+) cells with HIV-1-derived lentiviral vectors. Mol Ther 2000; 2: 71-80.
17. Cara A et al. Self-limiting, cell type-dependent replication of an integrase-defective human immunodeficiency virus type 1 in human primary macrophages but not T lymphocytes. Virology 1995; 208: 242-248.
18. Stevenson M et al. HIV-1 replication is controlled at the level of T cell activation and proviral integration. EMBO J 1990; 9: 1551-1560.
19. Cherry SR et al. Retroviral expression in embryonic stem cells and hematopoietic stem cells. Mol Cell Biol 2000; 20: 7419-7426.
20. + T lymphocytes: R5 but not X4 viruses replicate in the absence of T-cell receptor restimulation. J Virol 1999; 73: 7515-7523.
21. Weiss RA, Tailor CS. Retrovirus receptors. Cell 1995; 82: 531-533.
22. Saha K et al. Generation of CD4+ and CD8+ T-cell clones from PBLs of HIV-1 infected subjects using herpesvirus saimiri. Nat Med 1996; 2: 1272-1275.
23. Vella C et al. Enhanced replication of M-tropic HIV-1 strains in Herpesvirus saimiri immortalised T-cells which express CCR5. J Virol Methods 1999; 79: 51-63.
24. Sandrin V et al. Lentiviral vectors pseudotyped with a modified RD114 envelope glycoprotein show increased stability in sera and augmented transduction of primary lymphocytes and CD34+ cells derived from human and nonhuman primates. Blood 2002; 100: 823-832.
25. Miletic H et al. Retroviral vectors pseudotyped with lymphocytic choriomeningitis virus. J Virol 1999; 73: 6114-6116.
26. Pottathil R et al. Role of cell membrane composition in receptor-mediated internalization of vesicular stomatitis virus in human HEp-2 cells. J Biol Chem 1985; 260: 5265-5270.
27. Cao W et al. Identification of α-dystroglycan as a receptor for lymphocytic choriomeningitis virus and Lassa fever virus. Science 1998; 282: 2079-2081.
28. Chang TL et al. CAF-mediated human immunodeficiency virus (HIV) type 1 transcriptional inhibition is distinct from alpha-defensin-1 HIV inhibition. J Virol 2003; 77: 6777-6784.
29. Hatziioannou T et al. Restriction of multiple divergent retroviruses by Lv1 and Ref1. EMBO J 2003; 22: 385-394.
30. Vella C et al. Herpesvirus saimiri-immortalized human T-cells support long-term, high titred replication of human immunodeficiency virus types 1 and 2. J Gen Virol 1997; 78 (Part 6): 1405-1409.
31. + T-cell lines: an efficient target cell system for the analysis of human immunodeficiency virus-specific cytotoxic CD8+ T-lymphocyte activity. J Virol 1998; 72: 1627-1631.
32. Henderson EE et al. Altered replication of human immunodeficiency virus type 1 (HIV-1) in T cell lines retrovirally transduced to express Herpesvirus saimiri proteins StpC and/or Tip. Virology 1999; 264: 125-133.
33. Zufferey R et al. Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo. Nat Biotechnol 1997; 15: 871-875.
34. Demaison C et al. High-level transduction and gene expression in hematopoietic repopulating cells using a human immunodeficiency virus type 1-based lentiviral vector containing an internal spleen focus forming virus promoter. Hum Gene Ther 2002; 13: 803-813.
35. Soneoka Y et al. A transient three-plasmid expression system for the production of high titer retroviral vectors. Nucleic Acids Res 1995; 23: 628-633.
36. Romero P et al. Expression of CD94 and NKG2 molecules on human CD4(+) T cells in response to CD3-mediated stimulation. J Leukoc Biol 2001; 70: 219-224.